Events

Brave new world: Building Europe’s capacities for defence and security R&D
OCT
Thu
17
13:30 - 17:00

This was 1 year ago

Location

Brussel

ACE events, 22 Avenue d'Auderghem, Bruxelles 1040 BE
Programmes
Security Digital, Industry & Space Cybersecurity Defence EDF NATO-EDA Space

"Brave new world: Building Europe’s capacities for defence and security R&D" event is a public conference promoted by Science|Business to address critical questions related to European Defence and Security research and development (R&D). 

The event is designed to convene high-level representatives from EU institutions, national governments, academia, leading research institutions and key industry sectors such as aerospace, defence, AI, and cybersecurity. The aim is to provide a platform to foster discussions on European defence strategies, funding opportunities, and international cooperation.

The agenda is structured around three central themes:

  1. The need for a "total security" approach, which acknowledges that modern threats are not only military but also cyber, economic, and infrastructural. This perspective necessitates robust R&D development value chains integrating civilian, dual-use, and military research. The role of a prospective new defence commissioner will be a focal point.
  2. The event will  examine the European defence industrial strategy, and the challenge of balancing sovereignty and autonomy with global technological advancements. Discussions will explore how EU procurement and R&D policies can boost cooperation with international partners.
  3. The conference will address the critical question of financing Europe’s future defence and security R&D agenda moving forward, including the European Defence Fund, Horizon Europe & FP10, Digital Europe and NATO’s DIANA programme  A key related topic will be to gather industry recommendations on how to increase pre-competitive collaboration in defence and security R&D.

More information on this event can be found on the organiser's page.

  • Location: Brussels 
  • Access: Free

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.